ENTX - Entera Bio Ltd.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 2.16

Open

$ 2.19

Bid

$ 2.08 x 200

Ask

$ 0.00 x 0

Day's Range

$ 2.06 - $ 2.19

52 Week Range

$ 0.52 - $ 3.35

Volume

235,418

Average Volume

Market Cap

62.66M

Beta (5Y Monthly)

$ 1.41

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-08-2024	12-31-2023	10-K
2	11-14-2023	09-30-2023	10-Q
3	08-11-2023	06-30-2023	10-Q
4	05-05-2023	03-31-2023	10-Q
5	03-31-2023	12-31-2022	10-K
6	11-10-2022	09-30-2022	10-Q
7	08-11-2022	06-30-2022	10-Q
8	05-12-2022	03-31-2022	10-Q
9	03-08-2022	12-31-2021	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Entera Bio Announces Publication Of Oral P...
04/08/2024 12:33:29

Entera Bio Ltd. (NASDAQ:ENTX), ("Entera" or the "Company") a leader in the development of orally delivered pept...

HC Wainwright & Co. Maintains Buy on Enter...
04/02/2024 12:54:27

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Entera Bio (NASDAQ:ENTX) with a Buy and maintains $10 price tar...

Entera Bio Announces Key Regulatory Milest...
03/26/2024 12:33:46

Entera Bio Ltd. (NASDAQ:ENTX) ("Entera" or the "Company"), a leader in the development of orally delivered pept...

Entera Bio Announces Pharmacokinetic Data ...
03/20/2024 12:03:25

Entera Bio FY23 EPS $(0.31) Vs $(0.41) YoY...
03/08/2024 21:17:40

Financial Results for the year Ended December 31, 2023As of December 31, 2023, Entera had cash and cash equivalents of $11.0 mi...

Entera Bio Regains Compliance With Nasdaq ...
03/04/2024 13:47:35

Entera Bio Ltd. (NASDAQ:ENTX), ("Entera" or the "Company") a leader in the development of orally delivered pept...

entera-bio-and-3-other-stocks-under-1-insiders-are-buying

Entera Bio And 3 Other Stocks Under $1 Ins...
01/12/2024 12:48:34

The Dow Jones index closed slightly higher on Thursday. When insiders purchase or sell shares, it indicates their confidence or...

Entera Bio Announced That It Received An E...
01/03/2024 13:49:28

HC Wainwright & Co. Reiterates Buy on Ente...
12/11/2023 11:42:24

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Entera Bio (NASDAQ:ENTX) with a Buy and maintains $10 price ta...

Interim Results From Ongoing Clinical Stud...
11/29/2023 13:33:37

Entera Bio Ltd. (NASDAQ:ENTX), ("Entera" or the "Company") a leader in the development of orally delivered pept...

Entera Bio Reports Rapid Pharmacodynamic R...
10/16/2023 12:20:22

Entera Bio Ltd. (NASDAQ:ENTX), ("Entera" or the "Company") a leader in the development of orally delivered pept...

HC Wainwright & Co. Reiterates Buy on Ente...
09/13/2023 10:33:06

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Entera Bio (NASDAQ:ENTX) with a Buy and maintains $10 price ta...

Entera Bio Announces Collaboration with OP...
09/12/2023 12:32:58

Entera Bio Ltd. (NASDAQ:ENTX, ", Entera", )))) and OPKO Biologics, Inc., a subsidiary of OPKO Health, Inc. (NASDAQ:OPK,...

HC Wainwright & Co. Reiterates Buy on Ente...
09/11/2023 10:32:04

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Entera Bio (NASDAQ:ENTX) with a Buy and maintains $10 price ta...

Bioventus And 3 Other Stocks Under $5 Insi...
08/23/2023 13:23:06

The Dow Jones closed lower by 175 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or co...

$entera-bio-to-present-two-abstracts-on-its-once-daily-oral-hpth1-34-peptide-tablets-eb613-for-the-treatment-of-post-menopausal-women-at-high-risk-of-fracture-at-the-american-society-for-bone-and-mineral-research-annual-meeting$

Entera Bio To Present Two Abstracts On Its...
08/16/2023 12:35:17

HC Wainwright & Co. Reiterates Buy on Ente...
05/08/2023 10:28:23

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Entera Bio (NASDAQ:ENTX) with a Buy and maintains $10 price ta...

Entera Bio: Q1 Earnings Insights
05/05/2023 20:10:10

Entera Bio Q1 EPS $(0.08) Beats $(0.12) Es...
05/05/2023 20:07:54

Entera Bio (NASDAQ:ENTX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.12) by...

HC Wainwright & Co. Reiterates Buy on Ente...
04/04/2023 10:42:31

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Entera Bio (NASDAQ:ENTX) with a Buy and maintains $10 price ta...